Pharmacological therapy of newborn babies admitted to the neonatal intensive care unit

Fulvio Plescia, Anna Brancato, Carla Cannizzaro, Pietro Salvago, Francesco Dispenza, Angela Cavallaro, Federico Sireci, Francesco Dispenza, Gianluca Lavanco, Marianna Mucia, Serena Rizzo

Risultato della ricerca: Chapter

1 Citazione (Scopus)

Abstract

Newborn babies who need intensive medical care are often sheltered into a special area of the hospital called Neonatal Intensive Care Unit (NICU). In this structure, babies are regularly subject to conditions that would be considered harmful by older children and adults. In the last years, many clinical researches have paid particular attention to effectiveness of various pharmacological therapies, regularly used in neonatal intensive care that have sharply reduced mortality of newborn and preterm infants. Although there are many classes of drugs used for the treatment of different diseases (sepsis, pain, seizures, pulmonary hypertension and infection), the fledgling population is more difficult to handle because there are many physiological changes that happen in infants which do not occur at any other time of life. Furthermore, there are many drugs used during the first stage of life, able to induce various toxic effects on the principal organs and apparatus. For example, there are many relationships between amikacina serum levels and central conduction time in brainstem auditory evoked potentials within therapeutic range levels in newborns as index of drug toxicity in brainstem auditory centers in neonatally exposed infants. In this chapter, we will focus mainly on the principal pharmacological strategies used for dealing with neonatal diseases in the Neonatal Intensive Care Unit.
Lingua originaleEnglish
Titolo della pubblicazione ospiteNeonatal Intensive Care Units (NICUs): Clinical and Patient Perspectives, Levels of Care and Emerging Challenges
Pagine91-122
Numero di pagine32
Stato di pubblicazionePublished - 2017

Fingerprint

Neonatal Intensive Care Units
Newborn Infant
Pharmacology
Infant, Newborn, Diseases
Special Hospital
Neonatal Intensive Care
Auditory Cortex
Brain Stem Auditory Evoked Potentials
Poisons
Critical Care
Drug-Related Side Effects and Adverse Reactions
Pulmonary Hypertension
Premature Infants
Pharmaceutical Preparations
Brain Stem
Sepsis
Seizures
Therapeutics
Pain
Mortality

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cita questo

Plescia, F., Brancato, A., Cannizzaro, C., Salvago, P., Dispenza, F., Cavallaro, A., ... Rizzo, S. (2017). Pharmacological therapy of newborn babies admitted to the neonatal intensive care unit. In Neonatal Intensive Care Units (NICUs): Clinical and Patient Perspectives, Levels of Care and Emerging Challenges (pagg. 91-122)

Pharmacological therapy of newborn babies admitted to the neonatal intensive care unit. / Plescia, Fulvio; Brancato, Anna; Cannizzaro, Carla; Salvago, Pietro; Dispenza, Francesco; Cavallaro, Angela; Sireci, Federico; Dispenza, Francesco; Lavanco, Gianluca; Mucia, Marianna; Rizzo, Serena.

Neonatal Intensive Care Units (NICUs): Clinical and Patient Perspectives, Levels of Care and Emerging Challenges. 2017. pag. 91-122.

Risultato della ricerca: Chapter

Plescia, F, Brancato, A, Cannizzaro, C, Salvago, P, Dispenza, F, Cavallaro, A, Sireci, F, Dispenza, F, Lavanco, G, Mucia, M & Rizzo, S 2017, Pharmacological therapy of newborn babies admitted to the neonatal intensive care unit. in Neonatal Intensive Care Units (NICUs): Clinical and Patient Perspectives, Levels of Care and Emerging Challenges. pagg. 91-122.
Plescia F, Brancato A, Cannizzaro C, Salvago P, Dispenza F, Cavallaro A e altri. Pharmacological therapy of newborn babies admitted to the neonatal intensive care unit. In Neonatal Intensive Care Units (NICUs): Clinical and Patient Perspectives, Levels of Care and Emerging Challenges. 2017. pag. 91-122
Plescia, Fulvio ; Brancato, Anna ; Cannizzaro, Carla ; Salvago, Pietro ; Dispenza, Francesco ; Cavallaro, Angela ; Sireci, Federico ; Dispenza, Francesco ; Lavanco, Gianluca ; Mucia, Marianna ; Rizzo, Serena. / Pharmacological therapy of newborn babies admitted to the neonatal intensive care unit. Neonatal Intensive Care Units (NICUs): Clinical and Patient Perspectives, Levels of Care and Emerging Challenges. 2017. pagg. 91-122
@inbook{79151c5cea1d4e21b6045d054e074fdc,
title = "Pharmacological therapy of newborn babies admitted to the neonatal intensive care unit",
abstract = "Newborn babies who need intensive medical care are often sheltered into a special area of the hospital called Neonatal Intensive Care Unit (NICU). In this structure, babies are regularly subject to conditions that would be considered harmful by older children and adults. In the last years, many clinical researches have paid particular attention to effectiveness of various pharmacological therapies, regularly used in neonatal intensive care that have sharply reduced mortality of newborn and preterm infants. Although there are many classes of drugs used for the treatment of different diseases (sepsis, pain, seizures, pulmonary hypertension and infection), the fledgling population is more difficult to handle because there are many physiological changes that happen in infants which do not occur at any other time of life. Furthermore, there are many drugs used during the first stage of life, able to induce various toxic effects on the principal organs and apparatus. For example, there are many relationships between amikacina serum levels and central conduction time in brainstem auditory evoked potentials within therapeutic range levels in newborns as index of drug toxicity in brainstem auditory centers in neonatally exposed infants. In this chapter, we will focus mainly on the principal pharmacological strategies used for dealing with neonatal diseases in the Neonatal Intensive Care Unit.",
keywords = "Medicine (all)",
author = "Fulvio Plescia and Anna Brancato and Carla Cannizzaro and Pietro Salvago and Francesco Dispenza and Angela Cavallaro and Federico Sireci and Francesco Dispenza and Gianluca Lavanco and Marianna Mucia and Serena Rizzo",
year = "2017",
language = "English",
isbn = "9781536120578",
pages = "91--122",
booktitle = "Neonatal Intensive Care Units (NICUs): Clinical and Patient Perspectives, Levels of Care and Emerging Challenges",

}

TY - CHAP

T1 - Pharmacological therapy of newborn babies admitted to the neonatal intensive care unit

AU - Plescia, Fulvio

AU - Brancato, Anna

AU - Cannizzaro, Carla

AU - Salvago, Pietro

AU - Dispenza, Francesco

AU - Cavallaro, Angela

AU - Sireci, Federico

AU - Dispenza, Francesco

AU - Lavanco, Gianluca

AU - Mucia, Marianna

AU - Rizzo, Serena

PY - 2017

Y1 - 2017

N2 - Newborn babies who need intensive medical care are often sheltered into a special area of the hospital called Neonatal Intensive Care Unit (NICU). In this structure, babies are regularly subject to conditions that would be considered harmful by older children and adults. In the last years, many clinical researches have paid particular attention to effectiveness of various pharmacological therapies, regularly used in neonatal intensive care that have sharply reduced mortality of newborn and preterm infants. Although there are many classes of drugs used for the treatment of different diseases (sepsis, pain, seizures, pulmonary hypertension and infection), the fledgling population is more difficult to handle because there are many physiological changes that happen in infants which do not occur at any other time of life. Furthermore, there are many drugs used during the first stage of life, able to induce various toxic effects on the principal organs and apparatus. For example, there are many relationships between amikacina serum levels and central conduction time in brainstem auditory evoked potentials within therapeutic range levels in newborns as index of drug toxicity in brainstem auditory centers in neonatally exposed infants. In this chapter, we will focus mainly on the principal pharmacological strategies used for dealing with neonatal diseases in the Neonatal Intensive Care Unit.

AB - Newborn babies who need intensive medical care are often sheltered into a special area of the hospital called Neonatal Intensive Care Unit (NICU). In this structure, babies are regularly subject to conditions that would be considered harmful by older children and adults. In the last years, many clinical researches have paid particular attention to effectiveness of various pharmacological therapies, regularly used in neonatal intensive care that have sharply reduced mortality of newborn and preterm infants. Although there are many classes of drugs used for the treatment of different diseases (sepsis, pain, seizures, pulmonary hypertension and infection), the fledgling population is more difficult to handle because there are many physiological changes that happen in infants which do not occur at any other time of life. Furthermore, there are many drugs used during the first stage of life, able to induce various toxic effects on the principal organs and apparatus. For example, there are many relationships between amikacina serum levels and central conduction time in brainstem auditory evoked potentials within therapeutic range levels in newborns as index of drug toxicity in brainstem auditory centers in neonatally exposed infants. In this chapter, we will focus mainly on the principal pharmacological strategies used for dealing with neonatal diseases in the Neonatal Intensive Care Unit.

KW - Medicine (all)

UR - http://hdl.handle.net/10447/276443

UR - https://www.novapublishers.com/catalog/product_info.php?products_id=62049

M3 - Chapter

SN - 9781536120578

SP - 91

EP - 122

BT - Neonatal Intensive Care Units (NICUs): Clinical and Patient Perspectives, Levels of Care and Emerging Challenges

ER -